Mayo Clinic Cancer Center: Forefront Magazine

Forefront Online Edition

Director's message: 40 years and going strong
The Mayo Clinic Cancer Center celebrates 40 years as an NCI-designated cancer center.
Two-drug combination may slow deadly thyroid cancer
A combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer, a rare cancer that is resistant to most therapies.
Mayo Clinic gets approval for new prostate cancer imaging agent
Mayo Clinic is the only institution in North America approved to produce and administer Choline C 11 Injection, used to detect recurrent prostate cancer.
Researchers identify new molecule to target in pancreatic cancer
Researchers decode a molecular pathway that promotes pancreatic tumor growth, revealing new options for improving treatment.
Meet the investigator: S. Vincent Rajkumar, M.D.
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. This is Dr. Rajkumar's story.
Mayo Clinic in Arizona offers new treatment for recurrent brain tumors
A new treatment for glioblastoma slows and reverses tumor growth by inhibiting cell division and replication.